Invention Grant
- Patent Title: Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease
-
Application No.: US15543748Application Date: 2016-01-15
-
Publication No.: US10420796B2Publication Date: 2019-09-24
- Inventor: Sho Funayama , Risa Nodera , Takahiro Hatanaka
- Applicant: SEIKAGAKU CORPORATION
- Applicant Address: JP Tokyo
- Assignee: SEIKAGAKU CORPORATION
- Current Assignee: SEIKAGAKU CORPORATION
- Current Assignee Address: JP Tokyo
- Agency: Greenblum & Bernstein, P.L.C.
- Priority: JP2015-007072 20150116; JP2015-150976 20150730
- International Application: PCT/JP2016/051176 WO 20160115
- International Announcement: WO2016/114397 WO 20160721
- Main IPC: A61K31/738
- IPC: A61K31/738 ; A61K9/00 ; A61K9/08 ; A61P27/02
Abstract:
Provided is a chondroitin sulfate derivative having a cross-linked structure through a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on a corneal epithelial disorder and/or dry eye.
Public/Granted literature
- US20170368093A1 CROSSLINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE Public/Granted day:2017-12-28
Information query
